Different prognostic indices in 310 patients with tonsillar carcinomas

被引:12
作者
Hannisdal, K [1 ]
Boysen, M
Evensen, JF
机构
[1] Univ Oslo, Rikshosp, Dept Otorhinolaryngol, N-0027 Oslo, Norway
[2] Norwegian Radium Hosp, Dept Oncol, N-0310 Oslo, Norway
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2003年 / 25卷 / 02期
关键词
carcinomas of the tonsillar region; staging; survival; prognostic index; validity;
D O I
10.1002/hed.10175
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Several modifications of the TNM system have been reported as better prognostic tools than the original classification in head and neck cancer, but none of these modifications has been tested in a large series of tonsillar carcinomas. These studies did not examine host and treatment factors as predictors in addition to TNM. Methods. Three hundred and ten consecutively untreated patients with squamous cell carcinoma of the tonsillar region admitted to the Norwegian Radium Hospital and/or the National Hospital between 1960 and 1996 were included. Results. The five reported TN-based stage modifications were all highly significant predictors of survival. Four clinical variables indicating shorter disease-specific survival were identified: age > 60, male gender, total radiation dose < 70 Gy, and duration of radiotherapy > 50 days. Conclusions. Earlier reported TNM-based stage modifications are all very useful predictors of survival in tonsillar carcinomas. In addition, age, gender, total radiation dose, and duration of radiotherapy were important prognostic factors. We propose that both host and treatment factors should be tested carefully when building new prognostic indices in tonsillar carcinomas. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 29 条
[21]   Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: A randomized Phase III study [J].
Lewin, F ;
Damber, L ;
Jonsson, H ;
Andersson, T ;
Berthelsen, A ;
Biorklund, A ;
Blomqvist, E ;
Evensen, JF ;
Hansen, HS ;
Hansen, O ;
Jetlund, O ;
Mercke, C ;
Modig, H ;
Overgaard, M ;
Rosengren, B ;
Tausjo, J ;
Ringborg, U .
RADIOTHERAPY AND ONCOLOGY, 1997, 43 (01) :23-28
[22]   SQUAMOUS-CELL CARCINOMA OF THE OROPHARYNX - RESULTS OF PRIMARY RADIOTHERAPY [J].
LINDELOV, B ;
MONBERG, J ;
SAND, H .
ACTA ONCOLOGICA, 1992, 31 (03) :341-345
[23]   EXCLUSIVE RADIATION-THERAPY - THE TREATMENT OF EARLY TONSILLAR TUMORS [J].
LUSINCHI, A ;
WIBAULT, P ;
MARANDAS, P ;
KUNKLER, I ;
ESCHWEGE, F .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (02) :273-277
[24]   AJCC stage groupings for head and neck cancer: Should we look at alternatives? A report of the Head and Neck Sites Task Force [J].
Lydiatt, WM ;
Shah, JP ;
Hoffman, HT .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (08) :607-612
[25]  
MANTRAVADI RVP, 1978, CANCER-AM CANCER SOC, V41, P1054
[26]   Carcinoma of the tonsillar fossa: Prognostic factors and long-term therapy outcome [J].
Perez, CA ;
Patel, MM ;
Chao, KSC ;
Simpson, JR ;
Sessions, D ;
Spector, GJ ;
Haughey, B ;
Lockett, MA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (05) :1077-1084
[27]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39
[28]   SUPERIORITY OF THE T-AND-N INTEGER SCORE (TANIS) STAGING SYSTEM FOR SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY [J].
SNYDERMAN, CH ;
WAGNER, RL .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1995, 112 (06) :691-694
[29]   TIME FACTOR FOR TONSILLAR CARCINOMA [J].
THAMES, HD ;
BENTZEN, SM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (03) :755-758